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Abstract
Aflatoxin (AF) is polysubstituted bifuranocoumarins that are secondary fungal metabolites 
produced by parasiticus/flavus group of the genus Aspergillus. AF is hepatotoxic, nephro-
toxic, mutagenic, teratogenic, genotoxic, and immunotoxic, so the International Agency 
for Research on Cancer has classified AF as class I human carcinogen. AF-mediated cell 
injury may be associated with the release of free radicals, and these radicals initiate lipid 
peroxidation and a damaging process in biological systems since all cell membranes con-
tain the polyunsaturated fatty acids (PUFAs), which are substrates for such a reaction. One 
of the causes for AF-induced toxicity is the oxidative stress, which leads to the improved 
generation of reactive oxygen species (ROS) and the oxidative DNA damage. Lycopene, a 
naturally occurring carotenoid, has drawn a particular attention in recent years because of 
its high antioxidant activity and free radical scavenging capacity and has been shown to be 
effective against oxidative stress due to AF. Lycopene blocks Phase 1 metabolic enzymes of 
AFB such as 3A4, 2A6, and 1A2.
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1. Introduction
Mycotoxins are toxic products generated by fungi that are present spontaneously in food-
stuffs. Mycotoxins may be generated in foodstuffs at different stages from production to 
transfer and preservation processes. Chemical stability and persistence of mycotoxins make 
them long-lasting, and even after elimination of fungi, mycotoxins may exist in foodstuffs [1].
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Aflatoxin (AF) is the most abundant type of mycotoxins found in foodstuffs. Chemists iso-
lated AF from Aspergillus flavus and named it as AF by taking “a” from Aspergillus and “fla” 
from flavus. There are at least 20 intermediates of AFs generated from Aspergillus species [1, 
2]. AFs are found in the chemical construction of the furanocoumarins, and they possess two 
prominent structures: one of them is difurocoumarocyclopentenone (AFB1, AFB2, AFB2A, 
AFM1, AFM2, AFM2A, and aflatoxicol), and the other one is difurocoumarolactone (AFG1, 
AFG2, AFG2A, AFGM1, AFGM2, AFGM2A, and AFB3). AFs are named as AFB or AFG refer-
ring to the blue “B” or green “G” fluorescent color emitted by them under UV light on thin-
layer chromatography, while the subscript numbers 1 and 2, respectively, show major and 
minor compounds. Moreover, AFB1 and AFB2 metabolites that show up in body fluids are 
named as AFM1 and AFM2 (Figure 1) [3, 4].
AFs commonly contaminate cereals and cereal-based foods such as rice, maize, sorghum, 
millet, groundnuts, dried cassava, and many others during the storage and poor processing 
conditions. AFs not only contaminate foodstuff but are also found in edible tissues, milk, and 
eggs after consumption of contaminated feed by farm animals [1, 6]. Trout, rats, ducklings, 
cattle, poultry, and swine are some of the many animals that have been shown to be sensitive 
to AF [6]. According to AFB1 concentration, the organs may be classed as follows: gonads, 
liver, kidney, spleen, bursa cloacalis, thymus, endocrine glands, muscles, lungs, and brain 
[7]. Petr et al. [8] revealed that AFB1 was determined in the blood, kidney, liver, and testis to 
maximum 8–10 h after a single intraperitoneal (i.p.) injection at 0.1 mg/kg AFB1.
AFs are a group of naturally occurring food-borne poisons that have been associated with 
death and disease in humans and animals. They are of great worldwide concern due to their 
toxic effects on human and animal health [9]. Among all AFs, AFB1 is the most toxic, muta-
genic, and carcinogenic to both humans and livestock and is classified into group I as human 
carcinogen by the International Agency for Research on Cancer [10]. The extent of the car-
cinogenicity of AF depends on the presence of human health factors including hepatitis B 
virus infection, nutritional status, sex, and age as well as the amount of AF exposure [11, 12]. 
In transgenic mice, it was shown that overexpression of the hepatitis B virus large peptide 
Figure 1. Chemical structure of AFs (Adapted from Marin and Taranu [5]).
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envelope acted synergistically with AFB1 to have an effect on neoplastic development and 
other forms of chronic liver damage [13].
The immunotoxic potential of AF is known in many species, including laboratory and 
domestic animals [14]. In pigs, AF causes the decreases in blastogenic responses to mitogen, 
the reductions in complement titers, the decreases in macrophage activation, and the depres-
sion of delayed hypersensitivity responses [15]. Poultry is known to be extremely sensitive 
to the toxic effects of AFB1. Consumption of AFB1-contaminated feed causes a myriad of 
other effects either directly or indirectly associated with this toxicity: reduced feed utilization 
and efficiency, reduced growth rate, decreased body and organ weights [16], lowered egg 
production and reproductivity [17], immunosuppression [18], and increased susceptibility 
to disease [19].
2. Biotransformation (metabolism) of aflatoxins
AFs undergo biotransformation mainly in the liver. There are two types of biotransforma-
tions: Phase 1 and Phase 2. Phase 1 reactions are generally oxidative, reductive, or hydrolytic 
processes and provide a necessary chemical structure for Phase 2 reactions, which are gener-
ally conjugation reactions. Phase 1 reactions may result in activation as well as detoxification 
of a compound, whereas Phase 2 reactions, depending on conjugated cellular constituents, 
may lead either to detoxification or formation of biochemical lesions. Phase 1 is mostly medi-
ated by the cytochrome P450 (CYP450) enzyme systems. Phase 2 metabolism involves sulfate, 
glucuronide, glutathione (GSH), and amino acid conjugation reactions (Figure 2) [20].
2.1. Phase 1: Metabolism of aflatoxins
AB1 is oxidized by CYP450 subfamilies and specific isoforms of enzymes to several prod-
ucts. Only one of these, AFB1 epoxide, appears to be mutagenic, and others are detoxifica-
tion products. The putative AFB1 epoxide is generally accepted as the active electrophilic 
form of AFB1, which may attack nucleophilic nitrogen, oxygen, and sulfur heteroatoms in 
cellular constituents [22]. The CYP450-mediated oxidation to the extremely reactive AFB1-
8,9-epoxide is considered the primary (Phase 1) bioactivation pathway for AFB1 [23]. This 
conversion of AFB1, to the epoxide, is the phase of reaction that enables covalent binding 
to cellular macromolecules (e.g., DNA and/or protein) to occur. This reaction can involve 
a number of isozymes of CYP450 including 1A2 and 3A4 [24]. The AFB1-8,9-epoxide reacts 
with the N7 atom of guanine to form a pro-mutagenic DNA adduct (AF-N7-guanine). The 
DNA adducts are fairly resistant to DNA repair processes, and this causes gene mutation 
and thus the development of cancers especially the hepatocellular carcinomas (Figure 2) 
[21, 25].
CYP450 3A4, which can both activate and detoxicate AFB1, is found in the liver and small 
intestine. In the small intestine, the first contact after oral exposure, epoxidation, would not 
lead to liver cancer. CYP450 3A4 has been shown to play a major role in the activation of AFB1 
due to its intrinsic activity toward this substrate, and the high level of this enzyme is present 
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in human liver. CYP450 1A2 and some other human CYP450s also contribute, but they play 
a lesser role, even at relatively low AFB1 concentration [26, 27]. CYP450 3A4 forms mostly 
the genotoxic AFB-2,3-epoxide, whereas CYP450 1A2 forms both the exo- and nongenotoxic 
endoisomers [26]. CYP450 1A2 has high affinity for the bioactivation of AFB1 at low substrate 
concentrations following dietary exposure [21]. Some of the AFB1 intermediates go through 
far more metabolism in Phase 2 by binding with GSH in order to create the polar and less toxic 
compound that are simply excreted in urine and bile. However, AFBO and AFB1-dihydroxide 
intermediates led to carcinogenicity, while AFB2 causes acute toxicity, liver necrosis, and cel-
lular metabolizing enzyme inhibition (Figure 2) [28].
2.2. Phase 2: Metabolism of AF role of GSH conjugation in body detoxification of 
aflatoxins
Phase 2 reactions that lead to the detoxification involve conjugation to glucuronic acid, sulfate, 
and GSH. The AFB metabolites of Phase 1 metabolism undergo Phase 2 enzymatic metabo-
lism by glutathione-S-transferases (GSTs) that primarily catalyze conjugation reactions. After 
Phase 1 oxidation, AF can be readily conjugated with SH groups (in Phase 2 reactions) allow-
ing for further detoxification and elimination of the toxin. In a number of mammalian species, 
the AFB1-8,9-epoxide is efficiently conjugated with reduced GSH in a reaction catalyzed by 
GST (Figure 3) [29, 30].
Figure 2. Metabolism of AF in the liver. 1A2, CYP1A2; 3A4, CYP3A4; 3A5, CYP3A5; GST, glutathione-S-transferase; 
AFAR, AF aldehyde reductase; AF-SG, aflatoxin-glutathione conjugate [21].
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3. Free radicals and lipid peroxidation
Free radicals are highly reactive species that have an unpaired electron, e.g., hydroxyl 
(·OH) and superoxide radicals (O ̄2) which have potential to cause tissue damage (Figure 4). Although free radicals are highly reactive and potentially damaging, they are also an inte-
gral part of some cellular processes. Extracellular secretion of free radicals by leucocytes and 
microphages evokes immune response against bacteria, viruses, degenerated cells, and other 
foreign substances. Intracellular secretion of free radicals stimulates different cell signaling 
pathways and triggers oxidative stress defense response as well as apoptosis [31]. Due to 
Figure 3. Metabolism of AFB1. Glutathione and glutathione-S-transferase involved in detoxification of activated AFB1.
Figure 4. Different endogenous sources for ROS/reactive nitrogen species (RNS), antioxidant defense. Hydroxynonenal 
(HNE) is one of the end products of lipid peroxidation (adapted from Hardas [35]).
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perilous nature of free radicals, cells have a counter mechanism known as antioxidant defense 
to keep the free radical levels under check. Unfortunately, when certain conditions promote 
the excess production of free radicals or deplete the antioxidant defense that leads the cell to 
oxidative damage, oxidative stress is said to exist. Oxygen-derived free radicals are referred 
as reactive oxygen species (ROS). Oxygen radicals are produced as a consequence of the nor-
mal process of reduction of oxygen to water and represent by products of oxidative cellular 
metabolism. The main sites of ROS produced in living organisms are mitochondrial electron 
transport system, peroxisomal fatty acid, CYP450, and phagocytic cells [32]. ROS can react 
with DNA to cause breaks in the DNA chain and mutation, which could initiate carcinogen-
esis. Free radicals can react with membrane lipids leading to peroxidation of polyunsaturated 
fatty acid (PUFA) residues (Figure 4) [33, 34].
The majority of lipid peroxidation events that occur within the cell are result of free radical 
chain reaction. Oxidative damage to lipids generally results in formation of cytotoxic alde-
hyde and ketone derivatives. Typically free radicals have a very short half-life; therefore, the 
damage caused by them is localized. Unlike free radicals, lipid peroxidation products have 
a longer half-life, and so they can diffuse into bilayer and can cause oxidative damage away 
from their site of production. For a given fatty acid, multiple aldehydic or ketonic products 
can arise as a result of lipid peroxidation, depending upon which allylic carbon gets attacked 
to initiate the chain reaction [36, 37]. Malondialdehyde (MDA) is a significant final product, 
which composes via the degeneration of certain primary and secondary lipid peroxida-
tion products [38]. The MDA formation promotes the alteration of membrane fluidity and 
enhances of membrane fragility. Furthermore, MDA blocks particular enzyme reactions and 
causes mutagenicity and carcinogenicity by creating DNA adducts [39, 40].
4. Oxidative stress
Although ROS and reactive nitrogen species (RNS) are generated under normal physiologi-
cal conditions, their levels are efficiently regulated by antioxidant enzymes and molecules to 
maintain the cellular redox balance. Oxidative stress is defined as a disturbance in the balance 
between antioxidants and prooxidants, with increased levels of prooxidants leading to poten-
tial damage. This imbalance can be due to the decrease of endogenous antioxidants, low intake 
of dietary antioxidants, and/or increased formation of free radicals and other reactive species. 
In any case, either of both circumstances occurring together or separately eventually will lead 
to deleterious modifications of biomolecules and multitude of downstream consequences. 
Oxidative stress has been implicated in vast array of conditions including cancer, arthritis, 
cardiovascular diseases, diabetes, aging, and neurodegenerative disorders [33, 41, 42].
4.1. Effects on oxidative stress of aflatoxin
Oxidative stress plays a major role in aflatoxicosis. Oxidative stress may be due to direct effect 
of AFs themselves or by their metabolites. AFB1, a mutagenic food contaminant, is widely 
recognized as one of the most potent hepatocarcinogens in humans and experimental animals. 
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Metabolizing AFB1 increases the production of free radicals and lipid peroxides, resulting in 
cell damage [43, 44]. AFB1 is activated in the liver by CYP450 to AFB1-8,9-epoxide, which forms 
adducts with both DNA and protein. The toxic effects of AFs mostly arise from the binding of 
this particular epoxide derivative to DNA. AFs form after a series of highly organized oxida-
tion-reduction reactions. Several studies provided evidences indicating that CYP450 enzymes 
generate superoxide hydrogen peroxide (H2O2) as intermediate compounds, and these ROS can cause apoptosis and other cell pathologies [45–47]. AFB1 is able to induce ROS generation, 
which causes oxidative stress. The genetic toxicity of AFB1 is partly due to the accumulation of 
ROS such as O2−, ·OH, and H2O2 radical during the metabolic processing of AFB1 by CYP450 in the liver (Figure 5). These species may attack soluble cell compounds as well as membranes, 
eventually leading to the impairment of cell functioning and cytolysis [48].
It has been reported that there is free radical generation during AFB1 metabolism, and oxi-
dative damage is one type of damage caused by AFB1 [49, 50]. Oxidative damage induced 
by these ROS can, in turn, cause tissue damage by a variety of mechanisms including DNA 
damage, lipid peroxidation, protein oxidation, and depletion of thiols. The oxidative stress 
caused by AFB1 may be one of the underlining mechanisms for AFB1-induced cell injury and 
DNA damage, which eventually lead to tumorigenesis [37]. Studies have revealed that AFB1 
alters cell cycle and apoptosis-signaling pathways in liver cell models [43, 47, 51, 52]. AFB1 
can cause an increase in ROS formation in animals’ target organs including rat liver, duck 
liver, and mouse lung [37, 44, 53]. It is indicated that AFB1 induced an important liver cell 
injury, as shown by the significant increase in nitric oxide, but also a strong lipid peroxidation 
in the liver and kidney, accompanied with a significant decrease in total antioxidant capacity 
in rats [53], mice [54], and chicken [55]. Also, it was shown that a strong inducible nitric oxide 
synthase (iNOS) and nitrotyrosine immunoreactivity were observed in the livers of chicks 
administered with 300 ppb of AF. Moreover, AFB1 carcinogenicity is associated with altered 
expression of many p53-target genes and induction of mutations, principally the p53 codon 
249 hotspot mutation [13, 48].
AFs are claimed as potential risk factor of hepatocarcinoma, and the oxidative stress is consid-
ered to be a main factor in the initiation and the progression of liver cirrhosis, which is known 
Figure 5. Effect of AFs on the oxidative stress, the alleviating role of antioxidants (adapted from Marin and Taranu [5]).
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to be a pioneer of human hepatocellular carcinoma [11]. The oxidative damage caused by AF is 
considered to be the main mechanism leading to the subsequent hepatotoxicity [56]. AFB1 may 
disturb the integrity of cell membranes by stimulating phospholipid A2 to initiate lipid peroxida-
tion in cells [57]. Animals fed with AF-contaminated diet suffer from oxidative stress as indicated 
by the significant increment of lipid peroxidation and the significant reduction of enzymatic 
antioxidant such as SOD and GSH-Px [54, 58, 59]. According to the pioneering work of Shen et 
al. [60], AFB1 promotes lipid peroxidation in rat liver, and lipid peroxidation is intimately linked 
with liver cell injury. A time- and dose-dependent increase in 8-hydroxy-2′-deoxyguanosine 
(8-OHdG) was observed in DNA after a single intraperitoneal injection of AFB1. It reveals that 
AFB1 leads to oxidative DNA damage in rat liver, which may participate in ·OH as the initiat-
ing species. Therefore, factors having an effect on formation or action of  .OH would affect the 
generation of 8-OHdG.
It is well known that a possible mechanism of AF cytotoxicity is the induction of oxidative 
stress. The induction of oxidative stress is commonly related to an imbalance between the oxi-
dants and the antioxidant systems [49]. It is explained by its effect on mitochondria; increased 
lipid peroxidation; increased adduct formation with DNA, RNA, and protein; or all the three. 
Damage to mitochondria can lead to mitochondrial diseases and may be responsible for aging 
mechanisms. The damage can cause mitochondrial DNA (adducts and mutation), mitochon-
drial membranes, as well as disruption of energy production (production of adenosine tri-
phosphate) [61]. The mycotoxin alters energy-linked functions of adenosine diphosphate 
(ADP) phosphorylation and flavin adenine dinucleotide (FAD) and nicotinamide adenine 
dinucleotide (NAD)-linked oxidizing substrates and α-ketoglutarate-succinate cytochrome 
reductases [62, 63]. It causes ultrastructural changes in mitochondria and also induces mito-
chondria-directed apoptosis [51]. AFB1 induced the production of free radicals and the reduc-
tion of antioxidant defenses in livers of murine, human lymphocytes, and bovine peripheral 
blood mononuclear cells [51, 64, 65].
4.2. Aflatoxin and carcinogenicity
AFB1 primarily causes hepatocellular carcinoma and cholangiocarcinoma in the liver [11]. 
Among various types of known AFs, AFB1 is the most potent hepatocarcinogen; however, G1 
and B2 also cause cancers but with reduced potency. It causes liver tumors in mice, rats, fish, 
marmosets, tree shrews, and monkeys following the administration by various routes. The 
types of cancers described in research animals include hepatocellular carcinoma, cholangio-
cellular cancer, and adenocarcinoma of the gallbladder [66].
Besides, the liver tumors have also been reported to develop AF feeding in lacrimal glands, 
squamous cells of the tongue, esophagus, trachea, lung adenomas, osteogenic sarcoma, 
and carcinoma of the pancreas [66–68]. Carcinoma of the colon has been reported by many 
researchers [67, 69]. AF exposure contributes to the risk for development of hepatocellular 
carcinoma in ducklings [70]. AFB1 can cause hepatocarcinogenesis and mutation in rat liver 
(Figure 6) [71]. Ghebranious and Sell [13] proposed that some mutant proteins may act as a 
promoting agent for AFB1 hepatocarcinogenesis. AF and p53 expressions interact to produce 
malignant liver tumors transgenic in mice.
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4.3. Aflatoxins and oxidative lipid damage
Polyunsaturated lipids are essential for cells, being important constituents of cell membranes, 
endoplasmic reticulum, and mitochondria. Thus, the disruption of their structural properties 
could have consequences for cellular function. Lipid peroxidation is one of the main factors 
responsible for structural and functional alterations of the cell membrane following oxidative 
stress [39] and initiation of carcinogenesis [37, 54].
It remains unknown if the mycotoxins promote the lipid peroxidation directly through the 
enhancement of the ROS formation or the enhancement of the tissue sensitivity to the peroxi-
dation is the result of the compromised antioxidant defense, but it appears that both processes 
are taken part. AFB1-mediated cell injury may be due to the release of free radicals that initiate 
lipid peroxidation. The initiation of lipid peroxidation is caused by the attack of any species 
Figure 6. Overview of metabolic pathways leading to toxicity and carcinoma of AFB1 [72].
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that has sufficient reactivity to remove a hydrogen atom from a methylene group upon a 
PUFA [37, 54]. The peroxidation of PUFAs can be realized not only through nonenzymatic free 
radical-induced pathways but also through processes that are catalyzed by enzymes as cyclo-
oxygenase and lipoxygenase [39]. It is shown that also 8,9-epoxide increases lipid peroxida-
tion, followed by loss of membrane stability and the blockage of the membrane-bound enzyme 
activity [73]. Evaluation of the lipid damage is based on measurement of Thiobarbituric acid 
reactive substances (TBARS) or MDA by the TBA test and conjugated dienes. AFB1 induced 
an increase in the TBARS concentration in the liver [74] or in human hepatoma cells [75]. The 
increase of the lipid peroxide synthesis is observed not only in the liver but also in the kidney 
and brain [7, 35, 41]. This alteration was associated with a significant increase in conjugated 
diene formation. Concentrations of MDA+ 4-hydroxyalkenals as an index of lipid peroxida-
tion are increased by AFB1 in the liver, lung, brain, and testis, but not the kidney of male 
Wistar rats [76]. 4-Hydroxynonenal (4-HNE), a major electrophilic by-product of lipid per-
oxidation caused by oxidative stress, interacts with DNA to form exocyclic guanine products, 
which have been shown to increase in a rat model of hepatocarcinogenesis. AFB1 induces lipid 
peroxidation in rat liver, which may be an underlying mechanism of carcinogenesis [44, 77].
4.4. Aflatoxins and oxidative protein damage
ROS can also lead to oxidation of amino acid residue side chains, formation of protein-protein 
cross-linkages, and oxidation of the protein backbone resulting in protein fragmentation, and 
the modified forms of proteins will accumulate in organism [78]. By its capacity to generate 
ROS, AFB1 can promote the ROS-mediated oxidative damages in proteins (Figure 6) [79].
AFB1 could inhibit some (serine) proteolytic enzymes responsible for the degradation of dam-
aged proteins, with consequent relevant implications in hepatocarcinogenesis [79, 80]. It has 
been suggested that numerous action of AFs may be brought about their interactions with the 
proteasome, the main enzyme family account for the decomposition of most of cytosolic and 
nuclear proteins in eukaryotic cells. In fact, AFB1 brings about an inhibition of cellular 20S pro-
teasomes, affecting the cellular defense against oxidative stress. Because 20S proteasome is the 
proteolytic machinery responsible for removing oxidized proteins, its inhibition could con-
tribute to a higher protein carbonyl content observed in cultured hepatoma cell lysates [81].
The reduction of protein synthesis in animals treated with AFs may affect certain metal ions, 
which play an important role in free radical production and liberation. Inhibition of protein 
synthesis caused by AFs alters serum protein composition, resulting in suppression of the 
production of nonspecific humoral substances important to native defense [82]. At higher 
doses, AFB1 lowers the level of IgG and IgA in chick resulting in decreased acquired immu-
nity. Antibodies to AFB1 have been reported in humans [83, 84].
4.5. Aflatoxins and oxidative DNA damage
Oxidative DNA damage is a general definition for all types of changes (structural or func-
tional) of DNA, due to the interaction of ROS with DNA. The connection of ·OH to the C8 
position of DNA guanine forms C8-OH-adduct radical [85], which is eventually altered to 
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8-OH-guanine (8-OH-Gua) by one-electron oxidation [86]. While impaired lipids and pro-
teins can be removed by metabolic cycle of these compounds, damaged DNA has to be 
fixed in situ or destroyed by apoptotic processes; conversely, mutations result in the absence 
of these [87]. In humans, 8-OH-Gua glycosylase is the primary enzyme for the repair of 
8-OH-Gua in short-patch base excision repair. The excised form of 8-OH-Gua is a pro-
mutagenic adduct, 8-OHdG, which is excreted into urine without further metabolism and is 
stable for a significant time. 8-OHdG is widely considered as a key biomarker of oxidative 
DNA damage [60, 88].
The toxic and carcinogenic effects of AFB1 are intimately linked with its biotransformation 
[12]. There is a tendency for AFs especially AFB1 to convert into the epoxide and produce 
DNA adducts resulting in the formation of DNA strand breaks and mutations [88, 89]. It is 
well known that AFB1 is activated by the hepatic CYP450 enzyme system to form a highly 
reactive product, AFB1-8,9-epoxide, which subsequently connects to nucleophilic sites in 
DNA and the major adduct 8,9-dihydro-8-(N7-guanyl)-9-hydroxy-AFB1 (AFB1-N7-Gua) is 
formed. The formation of AFB1-DNA adducts is regarded as a critical step in the initiation of 
AFB1-induced hepatocarcinogenesis (Figure 7).
5. Aflatoxins and the antioxidant defense
The activity of antioxidant enzymes could induce as a result to the oxidative stress or could 
diminish through direct or indirect action of the mycotoxins. A part of the oxidative metabo-
lism intermediates of AFB1 composes a substrate for the Phase 2 detoxification enzymes. 
In a vast range of animal species, the fundamental way to detoxify the AFB1 is through the 
conjugation of AFBO with GSH. This way of detoxification is the principal way of AFB1 
excretion in many animal species. The reaction is catalyzed by GST [89]. It is observed that 
in mice, the reduced sensibility to AFs is correlated with the constitutive increase of GST iso-
enzyme [29]. GSH and GST are effective antioxidant enzymes that take part in the protection 
of tissues from harmful effects of AFB1 (Figure 3) [90, 91]. GSH is used as a cofactor by GST 
that conjugates GSH with endogenous substances like estrogens, exogenous electrophiles 
like AFs and its metabolites, and other various xenobiotics. The increased depletion of GSH 
Figure 7. Metabolic activation of AFB1 (adapted from Kobertz et al. [90]).
The Effect on Oxidative Stress of Aflatoxin and Protective Effect of Lycopene on Aflatoxin Damage
http://dx.doi.org/10.5772/intechopen.69321
77
leads to abnormally high levels of ROS in cells. AF is one of the main actors in depletion 
of GSH. The depletion of GSH affects metabolic processes such as catalysis of molecular 
oxygen (O2) to H2O2 by GSH-Px, and thus the integrity of the cell membranes disrupts. Its reduction further enhances the damage to critical cellular components (DNA, lipids, pro-
teins) by the AFB1-8,9-epoxides that form adducts. GST catalyzes the conjugation of AFB1-
8,9-epoxide with GSH to form AFB1-GSH conjugate, thereby decreasing the intracellular 
GSH content [37]. The AF-GSH product undergoes the sequential metabolism in the liver 
and kidneys in which it is excreted as a mercapturic acid (AF-N-acetylcysteine) in urine [91, 
92]. It has been reported that AF administration results in excessive lipid peroxidation [53] 
with concomitant decrease in GSH [58], increased protein oxidation, and DNA damage in 
rat liver. The activity of GSH-Px, which is a constituent of GSH redox cycle, decreases during 
AFB1 administration. The reduction in GSH-Px activity by AFB1 may be due to a decrease 
in the availability of GSH and also alterations in their protein structure by ROS. The stud-
ies revealed that there were obvious increases in MDA and/or nitric oxide (NO) levels and 
decreases in both nonenzymatic antioxidant GSH level and enzymatic antioxidant GSH-Px, 
catalase (CAT), glutathione reductase (GR), and GST activities after administration with 
AFB1 in vivo or in vitro [41, 51, 64, 65].
The study showed that administration of AFB1 produced a marked oxidative impact as evi-
denced by a significant increase in MDA in the liver, kidneys, and heart of AF-treated rats. 
These alterations might have been triggered either by the direct effects of AFB1 or by the 
metabolites formed by AF and the free radicals, which were generated during the formation 
of these metabolites. Initiation of LPO by AFB1 is noted as one of the principal appearances 
of ROS-induced oxidative damage. The mechanism of free radical damage also includes 
ROS-induced peroxidation of polyunsaturated fatty acids in the cell membrane lipid bilayer 
which causes a chain reaction of LPO, thus damaging the cellular membrane, causing further 
oxidation of membrane lipids and proteins, and leading to DNA damage. The study also 
showed that a significant increase in the oxidative stress was accompanied by a concomitant 
decrease in the enzyme activities involved in the disposal of O2− and peroxides, namely, CAT and SOD, as well as GSH levels and its related enzymes (GST, GSH-Px). A significant 
increase observed in tissue MDA levels in AFB1-treated animals indicated that AF led to the 
generation of the high level of free radicals, which could not be tolerated by the cellular anti-
oxidant defense system. A significant decrease in these enzyme activities could be explained 
by their consumption during the conversion of free radicals into less harmful or harmless 
metabolites [49].
6. Lycopene
Lycopene is an acyclic hydrocarbon carotenoid responsible for the intense red color of toma-
toes (Figure 8). Lycopene does not exhibit provitamin A activity since it lacks the β-ionone 
ring structure which is characteristic in carotenoids that are precursors for vitamin A [93, 94]. 
Lycopene is a natural pigment and imparts a red color in the foods containing it. In foods, 
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lycopene is found predominantly in its trans-form (approximately 95.4% of total lycopene 
 content), whereas serum and tissues contain more cis-isomers of lycopene [95–97]. Lycopene 
is nontoxic and Generally Recognized as Safe by the US FDA (21 CFR 73.585) and the European 
Union (Directive 94/36/EC) for the use as a food additive and colorant [98].
6.1. The role of lycopene as antioxidant and implications
Lycopene acts as an antioxidant by virtue of its conjugated p-electron system, which can react 
with oxygen radical species such as peroxy and hydroxy radicals as well as non-radical spe-
cies such as ozone and H2O2 [99].
Lycopene has a robust antioxidant defense system, attributed to its acyclic structure, numerous 
conjugated double bonds, and high hydrophobicity, and thus prevents the onset of carcinogenesis 
and atherogenesis processes by protecting/stabilizing biomolecules such as DNA, proteins, 
lipids, and lipoproteins. Lycopene, as the main carotenoid in tomato products, possesses the 
greatest ability to quench singlet oxygen compared to the other carotenoids. It also scavenges 
the free radicals via three different mechanisms: adduct formation, electron transfer, and 
hydrogen atom transfer [100, 101]. Galano et al. [102] reported that lycopene and torulene are 
more reactive scavengers of peroxide radicals than β-carotene.
Lycopene is capable of acting as an antioxidant by virtue of its many conjugated double 
bonds. It is the most efficient neutralizer of singlet oxygen among all carotenoids and has also 
been found to be a potent scavenger of free radicals [94, 95]. The lycopene molecule reacts 
with free radicals to form a short-lived intermediate species, which later end up as lycopene 
decomposition products including apocarotenals, apocarotenones, and epoxides. Being a 
highly hydrophobic molecule, the greatest scavenging ability of lycopene is seen in lipophilic 
environments [94, 103]. After supplementing subjects with lycopene from different dietary 
sources, serum TBARS (a biomarker for lipid peroxidation) is significantly reduced, whereas 
nonsignificant reductions are observed in biomarkers for protein and DNA oxidation. Hence, 
lycopene may be a biologically important antioxidant by protecting membrane lipids from 
being oxidized which in turn preserves the integrity of cellular membranes [104].
Much of the evidence for the antioxidant function of lycopene comes from studies conducted 
with in vitro systems, and virtually all of them indicate lycopene to function as a superior 
dietary antioxidant. Being is a strong antioxidant, lycopene has been shown to reduce the 
amount of oxidative DNA damage and also decrease lipid peroxidation in cell culture and in 
rats in vivo [105–107]. Di Mascio et al. [108] compared the singlet oxygen quenching ability 
of various carotenoids, α-tocopherol, bile acids, and retinoic acid. They found lycopene to 
Figure 8. Structure of all-trans lycopene (C40H56).
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be the most efficient quencher among all, with a greater than twofold quenching potency. 
Lycopene is the most efficient carotenoid in reducing TBARS formation by 75% compared to 
control in multilamellar liposomes. In a study examining the relative ability of several anti-
oxidants in reducing carotenoid cations, it was found that lycopene was the most superior 
carotenoid antioxidant and the lycopene cation radical was the most stable carotenoid cation 
radical [109].
6.2. Protective effect of lycopene on aflatoxin damage
There are many reports indicating that lycopene is effective on inhibition of tumor formation 
and growth induced by chemical carcinogens in animals [107]. To sum up, in Figure 9, AFB1 
has two important metabolic pathways: Phase 1 includes metabolism and metabolic activa-
tion, and Phase 2 is detoxification [30]. AFM1, AFQ1, AFP1, and AFB1-8,9-epoxide are impor-
tant Phase 1 metabolites, and also AFB-N7-Gua and AFB-albumin complexes are specific 
markers formed, respectively, in the tissues and “serum or urine” during the AFB1 metabolic 
activation. The main Phase 2 detoxification outcome of AFB1-8,9-epoxide is AFB-N-acetyl cys-
teine (AFB-NAC) complex. AFB1 Phase 1 metabolism and the metabolic activation of AFB1 
are inhibited by lycopene. Moreover, lycopene highly activates the enzymes responsible for 
Phase 2 detoxification and causes to enhance production of AFB-NAC excreted in urine. 
As shown in decreased urinary levels of AFP1, AFQ1, and AFM1 in lycopene-pretreated or 
lycopene-intervened animals, lycopene pretreatment or intervention significantly blocks 
Phase 1 metabolism of AFB1. This indicates that lycopene may selectively inhibit Phase 1 
metabolic enzymes such as 3A4, 2A6, and 1A2. Depending on the relative potency in decreas-
ing levels of these specific AFB1 metabolites in urine, lycopene appears to be a moderate 
competitive inhibitor of 3A4 and 2A6 enzymes and a weak or reversible inhibitor of 1A2 
Figure 9. AFB1 metabolic activation, biomarkers, and possible mechanisms of lycopene modulation [110].
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enzyme (more potent inhibition of AFP1 and AFQ1 than AFM1). Reducing levels of AFB-
albumin adducts in serum, reducing levels of AFB-N7-Gua excreted in urine, and reducing 
levels of AFB-N7-Gua adduct in the liver, DNA confirmed the inhibitory effect of lycopene on 
Phase 1 metabolism. These data clearly demonstrate that lycopene pretreatment or interven-
tion effectively blocks AFB1 metabolism and also metabolic activation. AFB-NAC is the major 
detoxifying metabolic product of AFB1-8,9-epoxide. Lycopene pretreatment and interven-
tion elevated significantly AFB-NAC levels in urine excretion, which suggests that activity of 
GSTs was greatly induced [30].
AFB1 also induces formation of ROS [44], lipid peroxidation, and formation of 8-OHdG in 
vivo and in vitro [60]. Lycopene could increase the activity of GSH-Px, GST, and GR in several 
animal models including rats [111]. The antioxidant capacity of lycopene is at extremely high 
levels and lessens not only the oxidative damage of DNA in particular rates but also lessens 
lipid peroxidation both in vitro and in vivo [105–107]. It has also been documented that lyco-
pene intervention reduces the 8-OHdG levels of urine even in recurring exposures to AFB1 
(Figure 10).
Administration of lycopene alleviates the negative effects of AF. Lycopene removes free radi-
cals produced by AF while improving the body’s antioxidant enzymes such as GSH, GSH-Px, 
and CAT to prevent the oxidative damage caused by AF, enhancing the body antioxidant 
capacity, reducing the levels of lipid peroxidation, and maintaining cell membrane perme-
ability. For this reason, natural antioxidant lycopene can be regarded as a good therapeutic 
agent against aflatoxicosis [112].
Figure 10. Inhibition of toxicity and cancer by lycopene in AFB1-exposed cells. Chemoprotective effects of lycopene 
effects are shown by arrows: ↑, increase; ↓, decrease (adapted from Reddy et al. [52]).
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7. Conclusion
Current concepts derived from intensive research on biotransformation, mechanisms of toxic-
ity, the effect on oxidative stress of AF, and protective effect of lycopene on AF damage were 
summarily presented in this chapter. AFB1 exerts its effects after conversion to the reactive com-
pound AFB1 epoxide by means of CYP450-dependent enzymes. This epoxide can form deriva-
tives with cellular macromolecules, including proteins, RNA and DNA. Biomonitoring of AFB1 
metabolites such as AFB1-N7-guanine has demonstrated that AFs constitute an important risk 
factor for hepatocellular carcinoma in highly exposed populations. Oxidative stress formed 
due to AF is associated with biochemical disturbances in oxidant/antioxidant balance system, 
which may cause AF toxicity. When administered together with AF, lycopene was determined 
that it exhibited strong positive effect on AF-induced oxidative stress parameters. It could be 
concluded that the lycopene being a nontoxic, highly promising natural “eco-friendly” antioxi-
dant compound has a protective effect against AF toxicity. When administered together with 
AF, lycopene was determined that it exhibited a strong positive effect on AF-induced oxidative 
stress parameters.
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